

Now Available:
Groundbreaking;
Voice of the
Hyperhidrosis Sufferer; Report
If you or a loved one lives with excessive sweating, The Voice of the Hyperhidrosis Sufferer is your report. Your participation, feedback and support surrounding the International Hyperhidrosis Society's Patient-Focused Drug Development Meeting on Hyperhidrosis helped to make it possible and it reflects the experiences and insights of true experts – the people like you who live with and suffer with hyperhidrosis. It’s time now to take this report and share it – to demand change in care, awareness, and treatments.
From 1951 to the present, the International Hyperhidrosis Society has the most comprehensive collection of sweat-related research papers around – so you can learn what the scientists know, and don’t know, about Hh. Learn more about the importance of our Know Sweat Published Literature content and how you can use it to be more Hh-informed.
miraDry is a non-surgical treatment for underarm sweating. Studies have shown that, for underarms, miraDry can provide 82% reduction in sweating – permanently! Today, with the chance to win treatment, miraDry’s new comfort-enhancing protocol, and debut patient education events, there’s more to miraDry than ever before.
A newly-published research article in the Journal of Drugs in Dermatology shows that hyperhidrosis patients wait YEARS (3 to 10 years, in fact) before seeking treatment and that some of the most commonly recommended treatments provide the least satisfaction. Read the full blog to discover all the key findings. Thank-you International Hyperhidrosis Society community for participating in this eye-opening study.
Here’s a story about an “ordinary” person making a difference. Shannon McLinden, founder of Summer Soles and FarmHouse Fresh, is a member of our community (just like you) and she’s using her businesses, her story, and her Texas ranch for positive change. Life with Hh can be hard, but if each of us strives to make a difference… that can make ALL the difference.
It’s been just over a month since our Patient-Focused Drug Development (PFDD) meeting on hyperhidrosis (Hh), but the process is not over. Your – and our -- input will help shape the future of hyperhidrosis care. PFDDs are an important way for us to make our voices and needs heard by treatment developers, healthcare providers, and the U.S. Food and Drug Administration (FDA). Have your say and comment via a “PFDD Comment” email.
This is a watershed moment for hyperhidrosis. The International Hyperhidrosis Society hosted a Patient-Focused Drug Development meeting in Washington, DC on November 13, 2017 designed to ensure that those affected by hyperhidrosis can make their voices – and needs -- heard by treatment developers, healthcare providers, and regulatory professionals from the U.S. Food and Drug Administration (FDA). If you’ve ever wanted a better way to control your sweating – and to stop sweating from controlling your life – it’s time to speak up - OPEN COMMENT PERIOD NEEDS YOUR INPUT NOW.
Latest Blogs